Provider of cytogenetic analysis services. The company's experimental protocol and proprietary bioinformatics analysis cover the full genome evenly with specific and accurate digital sequence output thus providing next generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics, and bioinformatics.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore InKaryo‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Xitong Li | Co-Founder and President |